Top compounds associated with response to VTA1


Feature Type Standardized
Nominal ANOVA
mRNA fluvastatin CTRPv2 pan-cancer AAC 0.11 0.002
mRNA CAY10603 GDSC1000 pan-cancer AAC 0.091 0.002
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.002
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA XMD13-2 GDSC1000 pan-cancer AAC 0.093 0.002
mRNA Topotecan CCLE pan-cancer AAC 0.13 0.003
mRNA Doxorubicin gCSI pan-cancer AAC 0.15 0.003
mRNA YK 4-279 GDSC1000 pan-cancer AAC 0.11 0.003
mRNA PD-0325901 GDSC1000 pan-cancer AAC -0.094 0.003
mRNA Camptothecin GDSC1000 pan-cancer AAC 0.097 0.003
Download CSV